Vyant Bio, Inc.

CIK 1349929 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Vyant Bio, Inc..

Recent SEC filings

FiledFormAccession number
Aug 16, 2023DEF 14A0001493152-23-029043
Jul 31, 2023PRE 14A0001493152-23-026105
May 15, 202315-12G0001493152-23-016921
May 10, 20238-K0001493152-23-016068
May 4, 2023250001493152-23-015454
Apr 24, 20238-K0001493152-23-013369
Mar 31, 202310-K0001493152-23-010255
Mar 27, 2023EFFECT9999999995-23-000666
Mar 27, 2023EFFECT9999999995-23-000675
Mar 27, 2023EFFECT9999999995-23-000669
Mar 27, 2023EFFECT9999999995-23-000671
Mar 27, 2023EFFECT9999999995-23-000670
Mar 27, 2023EFFECT9999999995-23-000667
Mar 24, 2023S-8 POS0001493152-23-008797
Mar 24, 2023POS AM0001493152-23-008801
Mar 24, 2023S-8 POS0001493152-23-008796
Mar 24, 2023POS AM0001493152-23-008803
Mar 24, 2023S-8 POS0001493152-23-008789
Mar 24, 2023POS AM0001493152-23-008802
Mar 24, 2023S-8 POS0001493152-23-008792
Mar 24, 2023POS AM0001493152-23-008806
Mar 24, 2023S-8 POS0001493152-23-008794
Mar 24, 2023POS AM0001493152-23-008800
Mar 24, 20238-K0001493152-23-008809
Mar 24, 2023POS AM0001493152-23-008798